Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Malaria Vaccines | 9 | 2013 | 21 | 3.090 |
Why?
|
Merozoite Surface Protein 1 | 12 | 2012 | 35 | 3.010 |
Why?
|
Antibodies, Protozoan | 12 | 2013 | 79 | 2.150 |
Why?
|
Plasmodium falciparum | 11 | 2011 | 135 | 2.140 |
Why?
|
Adjuvants, Immunologic | 6 | 2011 | 107 | 1.210 |
Why?
|
Malaria, Falciparum | 4 | 2011 | 90 | 1.060 |
Why?
|
Immunization | 4 | 2013 | 92 | 0.710 |
Why?
|
Malaria | 3 | 2013 | 78 | 0.680 |
Why?
|
Nanoparticles | 2 | 2012 | 318 | 0.600 |
Why?
|
Peptide Fragments | 4 | 2006 | 308 | 0.530 |
Why?
|
Vaccines, Synthetic | 5 | 2012 | 72 | 0.500 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 2013 | 57 | 0.500 |
Why?
|
Subtilisins | 1 | 2013 | 9 | 0.470 |
Why?
|
Rabbits | 6 | 2013 | 283 | 0.420 |
Why?
|
Ferric Compounds | 1 | 2012 | 51 | 0.420 |
Why?
|
Drug Carriers | 1 | 2012 | 125 | 0.400 |
Why?
|
Fellowships and Scholarships | 1 | 2011 | 29 | 0.390 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2011 | 88 | 0.390 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 6 | 2011 | 448 | 0.380 |
Why?
|
Mice | 10 | 2019 | 5913 | 0.380 |
Why?
|
Animals | 15 | 2019 | 15081 | 0.330 |
Why?
|
Lipid A | 1 | 2008 | 7 | 0.320 |
Why?
|
Mice, Knockout | 6 | 2019 | 933 | 0.320 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2007 | 56 | 0.300 |
Why?
|
Mice, Inbred C57BL | 6 | 2019 | 1609 | 0.290 |
Why?
|
Immune Sera | 1 | 2006 | 59 | 0.290 |
Why?
|
Interleukin-6 | 1 | 2007 | 153 | 0.280 |
Why?
|
Biomedical Research | 1 | 2011 | 400 | 0.280 |
Why?
|
Minority Groups | 1 | 2011 | 596 | 0.270 |
Why?
|
Students | 1 | 2011 | 519 | 0.270 |
Why?
|
Antigens, Protozoan | 3 | 2007 | 72 | 0.220 |
Why?
|
Dendritic Cells | 2 | 2012 | 113 | 0.200 |
Why?
|
Interleukin-4 | 3 | 2008 | 72 | 0.190 |
Why?
|
Interferon-gamma | 3 | 2008 | 250 | 0.180 |
Why?
|
Amino Acid Sequence | 2 | 2013 | 1180 | 0.170 |
Why?
|
Mice, Inbred BALB C | 3 | 2008 | 661 | 0.170 |
Why?
|
Molecular Sequence Data | 2 | 2013 | 1568 | 0.170 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2019 | 15 | 0.170 |
Why?
|
Colitis | 1 | 2019 | 65 | 0.160 |
Why?
|
Cytokines | 2 | 2012 | 602 | 0.160 |
Why?
|
Immunoglobulin G | 2 | 2011 | 237 | 0.160 |
Why?
|
Recombinant Proteins | 3 | 2011 | 515 | 0.160 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2019 | 172 | 0.150 |
Why?
|
Female | 7 | 2019 | 20969 | 0.150 |
Why?
|
Hotlines | 1 | 2017 | 14 | 0.140 |
Why?
|
Communicable Diseases, Emerging | 1 | 2017 | 12 | 0.140 |
Why?
|
Colonic Neoplasms | 1 | 2019 | 186 | 0.140 |
Why?
|
Vaccination | 1 | 1998 | 288 | 0.140 |
Why?
|
Immunodominant Epitopes | 1 | 1996 | 27 | 0.140 |
Why?
|
Antigens, Surface | 1 | 1996 | 43 | 0.140 |
Why?
|
Protein Precursors | 1 | 1996 | 61 | 0.140 |
Why?
|
B-Lymphocytes | 1 | 1996 | 185 | 0.130 |
Why?
|
Immunoglobulin Isotypes | 2 | 2008 | 16 | 0.120 |
Why?
|
Protozoan Proteins | 1 | 1996 | 182 | 0.120 |
Why?
|
Aotidae | 1 | 2012 | 4 | 0.110 |
Why?
|
Sequence Alignment | 1 | 2013 | 265 | 0.110 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2011 | 42 | 0.100 |
Why?
|
Quantum Dots | 1 | 2011 | 30 | 0.100 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 201 | 0.100 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2011 | 269 | 0.100 |
Why?
|
Alleles | 2 | 2006 | 321 | 0.100 |
Why?
|
Minority Health | 1 | 2011 | 88 | 0.090 |
Why?
|
Humans | 6 | 2017 | 37093 | 0.090 |
Why?
|
Cell Line | 2 | 2011 | 1354 | 0.090 |
Why?
|
Hawaii | 2 | 2017 | 1929 | 0.090 |
Why?
|
Schools | 1 | 2011 | 260 | 0.080 |
Why?
|
Macrophages | 1 | 2012 | 439 | 0.080 |
Why?
|
Emulsions | 1 | 2008 | 33 | 0.080 |
Why?
|
STAT6 Transcription Factor | 1 | 2008 | 16 | 0.080 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2007 | 24 | 0.080 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2007 | 71 | 0.080 |
Why?
|
Immunoglobulins | 1 | 2007 | 37 | 0.070 |
Why?
|
Antibody Formation | 1 | 2007 | 74 | 0.070 |
Why?
|
Spleen | 1 | 2007 | 199 | 0.070 |
Why?
|
Antibodies, Blocking | 1 | 2006 | 11 | 0.070 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2006 | 35 | 0.070 |
Why?
|
Antibody Specificity | 1 | 2006 | 79 | 0.070 |
Why?
|
Vaccines, Subunit | 1 | 2006 | 30 | 0.070 |
Why?
|
Epitopes | 1 | 2006 | 148 | 0.070 |
Why?
|
Genetic Vectors | 1 | 2002 | 158 | 0.050 |
Why?
|
United States | 1 | 2011 | 4223 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 1 | 2002 | 173 | 0.050 |
Why?
|
Adolescent | 1 | 2011 | 5363 | 0.050 |
Why?
|
Interleukin-16 | 1 | 2019 | 5 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2019 | 60 | 0.040 |
Why?
|
Gene Expression | 1 | 2002 | 674 | 0.040 |
Why?
|
Random Allocation | 1 | 2019 | 139 | 0.040 |
Why?
|
Reference Values | 1 | 2019 | 212 | 0.040 |
Why?
|
Species Specificity | 1 | 1998 | 245 | 0.040 |
Why?
|
Liposomes | 1 | 1998 | 118 | 0.040 |
Why?
|
Male | 2 | 2019 | 20025 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 562 | 0.040 |
Why?
|
Pacific Ocean | 1 | 2017 | 13 | 0.040 |
Why?
|
Down-Regulation | 1 | 2019 | 435 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2019 | 893 | 0.040 |
Why?
|
Aotus trivirgatus | 1 | 1996 | 1 | 0.040 |
Why?
|
Protozoan Vaccines | 1 | 1996 | 15 | 0.030 |
Why?
|
Binding, Competitive | 1 | 1996 | 111 | 0.030 |
Why?
|
Research | 1 | 2017 | 163 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2019 | 1371 | 0.030 |
Why?
|
Genetic Variation | 1 | 1996 | 387 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 807 | 0.030 |
Why?
|
Signal Transduction | 1 | 2019 | 1908 | 0.020 |
Why?
|
Bombyx | 1 | 2002 | 2 | 0.010 |
Why?
|
Sequence Analysis, Protein | 1 | 2002 | 50 | 0.010 |
Why?
|
Larva | 1 | 2002 | 124 | 0.010 |
Why?
|